Cargando…
Epigenetic Drugs and Their Immune Modulating Potential in Cancers
Epigenetic drugs are used for the clinical treatment of hematologic malignancies; however, their therapeutic potential in solid tumors is still under investigation. Current evidence suggests that epigenetic drugs may lead to antitumor immunity by increasing antigen presentation and may enhance the t...
Autores principales: | Liang, Yingying, Turcan, Sevin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8868629/ https://www.ncbi.nlm.nih.gov/pubmed/35203421 http://dx.doi.org/10.3390/biomedicines10020211 |
Ejemplares similares
-
Epigenetic Reprogramming for Targeting IDH-Mutant Malignant Gliomas
por: Park, Jong-Whi, et al.
Publicado: (2019) -
Epigenetic therapy: use of agents targeting deacetylation and methylation in cancer management
por: Ho, Allen S, et al.
Publicado: (2013) -
3D Whole-Brain Imaging Approaches to Study Brain Tumors
por: Taranda, Julian, et al.
Publicado: (2021) -
From Laboratory Studies to Clinical Trials: Temozolomide Use in IDH-Mutant Gliomas
por: Sun, Xueyuan, et al.
Publicado: (2021) -
Epigenetic modulation of the immune function: A potential target for tolerance
por: Suárez-Álvarez, Beatriz, et al.
Publicado: (2013)